Edentulous Mouth Clinical Trial
Official title:
Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants
Verified date | May 2022 |
Source | Euroteknika |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants
Status | Recruiting |
Enrollment | 868 |
Est. completion date | February 1, 2028 |
Est. primary completion date | July 1, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient aged 18 or over - Patient who has completed bone growth - Patient informed and agreeing to participate in the study - Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort) - Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort) - Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort) - Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort) Exclusion Criteria: - Pregnant or breastfeeding women (for the prospective cohort) - Patient with bone disease in the cervico-facial region - Patient refusing to participate in the study - Patient with at least one contraindication to implantation (for the prospective cohort) - Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort) - Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort) - Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort) - Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort) |
Country | Name | City | State |
---|---|---|---|
France | Chu Clermont Ferrand | Clermont Ferrand |
Lead Sponsor | Collaborator |
---|---|
Euroteknika | EVAMED |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The success rate of tissue integration of the implant | Integration of the implant 5 years after implantation | 5 years after implantation | |
Secondary | assessment of the quality of life of patients following the recovery of full dentition with the GOHAI score (General Oral Health Assessment Index) | the quality of life of patients will be evaluated with the GOHAI score before implantation and 5 years after implantation | 5 years after implantation | |
Secondary | Complication rate taking into account pain, local tenderness, infection, mobility of the implant, fracture | pain, local tenderness, infection, mobility of the implant, fracture will be collected during the 5 years follow-up | 5 years after implantation | |
Secondary | measuring chewing function after prosthesis placement | Occlusal assessment will be performed after implantation and at 5 years follow-up | 5 years after implantation | |
Secondary | Rate of inflammation (visual) | Assessment of inflammation with visual examination 5 years after implantation | 5 years after implantation | |
Secondary | Assessment of the evolution of the péri-implant tissues | assessment of the evolution of the péri-implant tissues with the Pink esthetic score | 5 years after implantation | |
Secondary | assessment of the osseointegration of the implant | assessment of the osseointegration of the implant with the ISQ score | 5 years after implantation | |
Secondary | Rate of infection (x-ray) | Assessment of infection with radiographic examination 5 years after implantation | 5 years after implantation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04984499 -
In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1
|
||
Completed |
NCT01411683 -
Mandibular Overdentures Retained by Conventional or Mini Implants
|
N/A | |
Completed |
NCT04853459 -
A Technique for Border Molding in Complete Dentures Using Light-Cured
|
N/A | |
Not yet recruiting |
NCT06458738 -
Clinical Evaluation of a New Printable Denture Base Material
|
N/A | |
Completed |
NCT01230320 -
Simplified vs. Conventional Methods for Complete Denture Fabrication
|
N/A | |
Completed |
NCT05614635 -
Safety and Technical Performance of Plastalgin and Plastalgin Fast in Patients Requiring a Dental Impression
|
||
Active, not recruiting |
NCT05599269 -
Retrospective Clinical Evaluation of Nano-hybrid-composite Denture Teeth
|
N/A | |
Not yet recruiting |
NCT03674554 -
Prosthetic Complications of Screw Retained Restoration
|
N/A | |
Not yet recruiting |
NCT06155630 -
3D Printing for the Fabrication of Mandibular Implant Overdentures
|
N/A | |
Active, not recruiting |
NCT02117856 -
Complete Lower Dentures on 1 or 2 Implants
|
N/A | |
Not yet recruiting |
NCT06393582 -
Accuracy Evaluation of Implant Impressions: A Prospective Study
|
N/A | |
Recruiting |
NCT06255522 -
Clinical and Anatomical Factors Influencing Accuracy in Fully Guided Implant Placement.
|
N/A | |
Completed |
NCT04760457 -
Mandibular Overdentures Retained by Mini Implants: a Clinical Trial Comparing Different Surgical and Loading Protocols
|
N/A | |
Completed |
NCT03126942 -
Single-implant Overdentures Retained by the Novaloc Attachment System
|
N/A | |
Enrolling by invitation |
NCT05441527 -
Use of Two Dissolvable Therapeutics Under Removable Partial Dentures
|
N/A | |
Completed |
NCT03056976 -
Cost-effectiveness of Implant Treatment for the Edentulous Mandible
|
N/A | |
Completed |
NCT04475913 -
Digital vs Analog Impression in Cases of All-on-4 - Prosthesis
|
N/A | |
Recruiting |
NCT03536468 -
Psychological Impact of Tooth Loss
|
||
Completed |
NCT03048812 -
Attachment Types for Single-implant Mandibular Overdentures: a Crossover Clinical Trial
|
N/A | |
Recruiting |
NCT02339194 -
Application of a Simplified Method of Complete Denture Fabrication for Severely Resorbed Mandibular Ridges
|
Phase 3 |